Compass Pathways Delays Key Phase 3 Data for Psilocybin Therapy, Cuts 30% of Workforce
Compass Pathways, a leading player in psychedelic-based mental health treatments, has announced a significant delay in the release of data ...
Tag: Psilocybin Therapy
